EUVIMEDEUVIMED entdecken
Crossref

Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes

Pierre Seners iD, Michael Mlynash, Adrien Ter Schiphorst, Anke Wouters iD, Nicole Yuen, Caroline Arquizan, Jeremy J Heit iD, Denis Sablot, Anne Wacongne, Thibault Lalu, Vincent Costalat, Gregory W Albers und 1 weitere

Annals of Neurology · 2025-10 · 98 (4) · 871-880

DOI: 10.1002/ana.27303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 19.06.2025. Verfasst von Pierre Seners und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France. Hauptthemen laut MEDLINE: Thrombectomy, Thrombolytic Therapy, Patient Transfer, Ischemic Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Edmond de Rothschild Foundation, Philippe Foundation, Fondation Bettencourt Schueller.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Patients with acute ischemic stroke and large vessel occlusion (LVO) often require transfer from primary stroke centers (PSCs) to thrombectomy‐capable centers. This study assessed the efficacy and safety of intravenous thrombolysis (IVT) initiated before inter‐hospital transfer.

Methods

Data from 2 prospective cohorts of patients with anterior circulation LVO transferred for thrombectomy from a PSC, regardless of whether thrombectomy was eventually attempted at the endovascular‐capable center, were analyzed. Efficacy outcomes included good 3‐month functional outcome (modified Rankin scale [mRS] = 0–2), excellent functional outcome (mRS = 0–1), and arterial recanalization during transfer. Safety outcomes included any intracerebral hemorrhage (ICH) and symptomatic ICH (sICH) at 24 hours. Propensity score with overlap weighting balanced the covariates between patients treated with IVT versus those without.

Results

Of 521 patients, 260 (50%) received IVT before transfer. IVT was withheld mainly due to being outside the 4.5‐hour window (58%) or anticoagulant use (21%). Median age was 72 years, 55% were men, and median baseline National Institutes of Health Stroke Scale (NIHSS) was 15. After propensity score with overlap weighting, patients receiving IVT more frequently had good functional outcome (odds ratio [OR] = 2.17, 95% confidence interval [CI] = 1.43–3.30, p < 0.01), excellent functional outcome (OR = 1.99, 95% CI = 1.21–3.25, p < 0.01), and inter‐facility recanalization (OR = 5.64, 95% CI = 2.92–10.89, p < 0.01) compared with patients not treated with IVT. Any ICH (OR = 1.14, 95% CI = 0.76–1.70) and sICH (OR = 0.73, 95% CI = 0.36–1.51) rates were similar between groups.

Interpretation

IVT before transfer was associated with improved recanalization and functional outcomes without increasing safety risks but is used in only 50% of patients. Expanding IVT criteria, including treatment beyond 4.5 hours and in anticoagulated patients, should be explored. ANN NEUROL 2025;98:871–880

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombectomyThrombolytic TherapyPatient TransferIschemic StrokeFibrinolytic AgentsHumansMaleFemaleAgedMiddle AgedTreatment OutcomeAged, 80 and overProspective StudiesAdministration, Intravenous

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France.
  • Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team Turc, Paris, France.
  • Stanford Stroke Center, Stanford University, Palo Alto, CA, USA.
  • Neurology Department, CHRU Gui de Chauliac, Montpellier, France.
  • Department of Neurosciences Division of Experimental Neurology, KU Leuven, Leuven, Belgium.
  • Radiology Department, Stanford University, Palo Alto, CA, USA.

ORCID-Profile: Pierre Seners, Anke Wouters, Jeremy J Heit

Förderung

  • Edmond de Rothschild Foundation
  • Philippe Foundation
  • Fondation Bettencourt Schueller
  • Institut Servier
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Seners, P., Mlynash, M., Ter Schiphorst, A., Wouters, A., Yuen, N., Arquizan, C., Heit, J. J., Sablot, D., Wacongne, A., Lalu, T., Costalat, V., Albers, G. W., & Lansberg, M. G. (2025). Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes. Annals of Neurology, 98(4), 871-880. https://doi.org/10.1002/ana.27303

Vancouver

Seners P, Mlynash M, Ter Schiphorst A, Wouters A, Yuen N, Arquizan C, et al. Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes. Annals of Neurology. 2025;98(4):871-880. doi:10.1002/ana.27303

BibTeX
@article{Seners2025,
  author = {Seners, Pierre and Mlynash, Michael and Ter Schiphorst, Adrien and Wouters, Anke and Yuen, Nicole and Arquizan, Caroline and Heit, Jeremy J and Sablot, Denis and Wacongne, Anne and Lalu, Thibault and Costalat, Vincent and Albers, Gregory W and Lansberg, Maarten G},
  title = {Intravenous Thrombolysis Use before Inter‐Facility Transfer for Thrombectomy: Association with Efficacy and Safety Outcomes},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {98},
  number = {4},
  pages = {871--880},
  doi = {10.1002/ana.27303}
}
Kostenlos starten →